Please login to the form below

companion diagnostic

This page shows the latest companion diagnostic news and features for those working in and with pharma, biotech and healthcare.

Loxo, Bayer get quick FDA review for ‘precision’ cancer drug

To try to address that issue, Loxo formed a partnership earlier this year with Illumina to develop a companion diagnostic – called TruSight Tumour 170 – that will use sequencing to identify whether

Latest news

EMA starts firming up its stance on personalised medicines

New draft European guidelines on personalised medicines and companion diagnostics are expected to be released by December 2018. ... As diagnostic medical devices, companion diagnostics do not fall within the oversight of the EMA, but the regulator is set
Celgene, Agios get FDA OK for leukaemia drug Idhifa

A companion diagnostic from Abbott Labs that detects mutations in the IDH2 gene in blood or bone marrow samples has been approved alongside the new drug.
AZ takes Chi-Med’s kidney cancer drug into phase III

He noted that the company has developed a companion diagnostic that will be used to select patients for its phase III programme.
AZ gets first OK for PD-L1 inhibitor durvalumab

The FDA also approved Roche's Ventana PD-L1 assay as a companion diagnostic for assessing PD-L1 protein levels in biopsy tissue.
Novartis' Rydapt approval ends long AML therapy drought

The US agency cleared Novartis' Rydapt (midostaurin) for use alongside chemotherapy in newly-diagnosed AML patients who carry the FLT3 mutation, also giving the okay for a FLT3 companion diagnostic developed

More from news
Approximately 1 fully matching, plus 66 partially matching documents found.

Latest Intelligence

Harnessing complexity

This delicate balance between companion diagnostics' clinical utility and their potential confounding impact on patient treatment is a growing dilemma. ... Answering this question in full requires a scientific journey to better understand what a
Diagnostics are rising up the pharma value chain

Diagnostic drivers. It's not just this idea of changing public attitudes that is creating renewed interest in the diagnostics sector; the sector is also influenced by the wider forces affecting ... GlaxoSmithKline and Boehringer Ingelheim have had
Deal Watch table for June 2014

50. NanoString Technologies/ Celgene. Development. Development of a companion diagnostic assay.
Pharma deals during June 2014

a deal with NanoString Technologies for the development of a companion diagnostic assay to support the development of Revlimid for treatment of Diffuse Large B-Cell Lymphoma at a more modest
Interview: John Dineen, GE Healthcare

some of these markers can be converted into a companion diagnostic product after the completion of a late-stage clinical trial. ... We can then ensure our diagnostic is closely coupled with the therapeutic capability.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

Mastering the precision medicine opportunity

Novartis and Roche are two champions of personalised medicine, shaping the area with the launch of targeted treatments combined with a companion diagnostic to support patient identification. ... multiple companion diagnostics.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager- 4 days per week or full-time: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Systematic Review Lead- London: Negotiable

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Market Access Consultant - Greater Manchester: Negotiable

Medical Writer - Creative and Scientific Projects: DOE

Senior Medical Writer: Salary is DOE

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Senior Training Manager - Surrey: Competitive Salary &Bonus

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Account Director, Healthcare Advertising Agency: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Sudler London - Account Director: Competitive

Editorial Director – Medical Education: Neg

Senior Writer, Healthcare Advertising, London: Excellent package

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager: Negotiable

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Subscribe to our email news alerts

PMHub

Add my company

Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....